EUVIMEDEUVIMED entdecken
Open Access

Determination of the cycle threshold value of the Xpert Xpress SARS-CoV-2/Flu/RSV test that corresponds to the presence of infectious SARS-CoV-2 in anterior nasal swabs

Ryan F Relich iD, Kayla Van Benten, Guang-Sheng Lei, Christopher M Robinson iD, Mariel Carozza, Malaya K Sahoo, ChunHong Huang, Daniel Solis, Mamdouh Sibai, Christopher A Myers, Cynthia Sikorski, Caroline Balagot und 3 weitere

Microbiology Spectrum · 2024

DOI: 10.1128/spectrum.03908-23 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microbiology Spectrum, 2024. Verfasst von Ryan F Relich und 14 weiteren Autor:innen. Beteiligte Einrichtung: Division of Clinical Microbiology, Indiana University Health, Indianapolis, Indiana, USA. Hauptthemen laut MEDLINE: COVID-19, Communicable Diseases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Cepheid (Cepheid Inc), Danaher.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Despite having high analytical sensitivities and specificities, qualitative SARS-CoV-2 nucleic acid amplification tests (NAATs) cannot distinguish infectious from non-infectious virus in clinical samples. In this study, we determined the highest cycle threshold (Ct) value of the SARS-CoV-2 targets in the Xpert Xpress SARS-CoV-2/Flu/RSV (Xpert 4plex) test that corresponded to the presence of detectable infectious SARS-CoV-2 in anterior nasal swab samples. A total of 111 individuals with nasopharyngeal swab specimens that were initially tested by the Xpert Xpress SARS-CoV-2 test were enrolled. A healthcare worker subsequently collected anterior nasal swabs from all SARS-CoV-2-positive individuals, and those specimens were tested by the Xpert 4plex test, viral culture, and laboratory-developed assays for SARS-CoV-2 replication intermediates. SARS-CoV-2 Ct values from the Xpert 4plex test were correlated with data from culture and replication intermediate testing to determine the Xpert 4plex assay Ct value that corresponded to the presence of infectious virus. Ninety-eight of the 111 (88.3%) individuals initially tested positive by the Xpert Xpress SARS-CoV-2 test. An anterior nasal swab specimen collected from positive individuals a median of 2 days later (range, 0–9 days) tested positive for SARS-CoV-2 by the Xpert 4plex test in 39.8% (39/98) of cases. Of these samples, 13 (33.3%) were considered to contain infectious virus based on the presence of cultivable virus and replication intermediates, and the highest Ct value observed for the Xpert 4plex test in these instances was 26.3. Specimens that yielded Ct values of ≤26.3 when tested by the Xpert 4plex test had a likelihood of containing infectious SARS-CoV-2; however, no infectious virus was detected in specimens with higher Ct values. IMPORTANCE Understanding the correlation between real-time PCR test results and the presence of infectious SARS-CoV-2 may be useful for informing patient management and workforce return-to-work or -duty. Further studies in different patient populations are needed to correlate Ct values or other biomarkers of viral replication along with the presence of infectious virus in clinical samples.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Communicable DiseasesHumansSARS-CoV-2NasopharynxMolecular Diagnostic TechniquesCOVID-19 Testing

Stichwörter der Autor:innen

SARS-CoV-2coronaviruscycle threshold (Ct) valuereal-time reverse transcription PCR

Autor:innen und Institutionen

  • Division of Clinical Microbiology, Indiana University Health, Indianapolis, Indiana, USA.
  • Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, Indiana, USA.
  • Becton, Dickinson and Company, Franklin Lakes, New Jersey, USA.
  • Department of Microbiology and Immunology, Indiana University School of Medicine, Indianapolis, Indiana, USA.
  • Genezen, Indianapolis, Indiana, USA.
  • Department of Pathology, Stanford University School of Medicine, Stanford, California, USA.

ORCID-Profile: Ryan F Relich, Christopher M Robinson, Benjamin A Pinsky, Michael J Loeffelholz

Förderung

  • Cepheid (Cepheid Inc)
  • Danaher

Zitieren

APA

Relich, R. F., Van Benten, K., Lei, G. S., Robinson, C. M., Carozza, M., Sahoo, M. K., Huang, C., Solis, D., Sibai, M., Myers, C. A., Sikorski, C., Balagot, C., Yang, D., Pinsky, B. A., & Loeffelholz, M. J. (2024). Determination of the cycle threshold value of the Xpert Xpress SARS-CoV-2/Flu/RSV test that corresponds to the presence of infectious SARS-CoV-2 in anterior nasal swabs. Microbiology Spectrum. https://doi.org/10.1128/spectrum.03908-23

Vancouver

Relich RF, Van Benten K, Lei GS, Robinson CM, Carozza M, Sahoo MK, et al. Determination of the cycle threshold value of the Xpert Xpress SARS-CoV-2/Flu/RSV test that corresponds to the presence of infectious SARS-CoV-2 in anterior nasal swabs. Microbiology Spectrum. 2024. doi:10.1128/spectrum.03908-23

BibTeX
@article{Relich2024,
  author = {Relich, Ryan F and Van Benten, Kayla and Lei, Guang-Sheng and Robinson, Christopher M and Carozza, Mariel and Sahoo, Malaya K and Huang, ChunHong and Solis, Daniel and Sibai, Mamdouh and Myers, Christopher A and Sikorski, Cynthia and Balagot, Caroline and Yang, David and Pinsky, Benjamin A and Loeffelholz, Michael J},
  title = {Determination of the cycle threshold value of the Xpert Xpress SARS-CoV-2/Flu/RSV test that corresponds to the presence of infectious SARS-CoV-2 in anterior nasal swabs},
  journal = {Microbiology Spectrum},
  year = {2024},
  doi = {10.1128/spectrum.03908-23}
}
Kostenlos starten →